You are here

  • Home
  • Archive
  • Volume 74, Issue Suppl 2
  • SAT0179 Ready to Use CE-IVD Smart Elisa Kits from Sanquin for Infliximab and Adalimumab Levels Correlate with the Golden Standard and can be Used for Optimisation of Personalised Treatment in RA Patients

Article info

Article menu
Download PDFPDF
Poster Presentations
Rheumatoid arthritis - anti-TNF therapy
SAT0179 Ready to Use CE-IVD Smart Elisa Kits from Sanquin for Infliximab and Adalimumab Levels Correlate with the Golden Standard and can be Used for Optimisation of Personalised Treatment in RA Patients

Authors

Citation

van Hensbergen Y, te Velthuis H
SAT0179 Ready to Use CE-IVD Smart Elisa Kits from Sanquin for Infliximab and Adalimumab Levels Correlate with the Golden Standard and can be Used for Optimisation of Personalised Treatment in RA Patients
Annals of the Rheumatic Diseases 2015;74:719-720.

Publication history

  • First published June 9, 2015.
Online issue publication 
April 13, 2016

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© 2015, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions